Per Malmström

affiliated with the university
More filtering options
  1. 2021
  2. Prognostic and predictive impact of stroma cells defined by PDGFRb expression in early breast cancer: results from the randomized SweBCG91RT trial

    Carina Strell, Axel Stenmark Tullberg, Reidunn Jetne Edelmann, Lars Andreas Akslen, Per Malmström, Mårten Fernö, Erik Holmberg, Arne Östman & Per Karlsson, 2021 May 1, In: Breast Cancer Research and Treatment. 187, 1, p. 45-55 11 p.

    Research output: Contribution to journalArticle

  3. Thromboembolism in Muscle-Invasive Bladder Cancer. A Population-based Nationwide Study

    Staffan Jahnson, Truls Gardmark, Abolfazl Hosseini, Tomas Jerlstrom, Fredrik Liedberg, Per Uno Malmstrom, Oskar Hagberg, Amir Sherif, Viveka Strock, Karin Soderkvist, Anders Ullen, Christel Haggstrom, Lars Holmberg & Firas Aljabery, 2021, In: Bladder Cancer. 7, 2, p. 161-171 11 p.

    Research output: Contribution to journalArticle

  4. 2020
  5. Expression of HGF, pMet, and pAkt is related to benefit of radiotherapy after breast-conserving surgery: a long-term follow-up of the SweBCG91-RT randomised trial

    Martin Sjöström, Cynthia Veenstra, Erik Holmberg, Per Karlsson, Fredrika Killander, Per Malmström, Emma Niméus, Mårten Fernö & Olle Stål, 2020 Nov, In: Molecular Oncology. 14, 11, p. 2713-2726 14 p.

    Research output: Contribution to journalArticle

  6. No Increased Cardiac Mortality or Morbidity of Radiation Therapy in Breast Cancer Patients After Breast-Conserving Surgery: 20-Year Follow-up of the Randomized SweBCGRT Trial

    Fredrika Killander, Elinore Wieslander, Per Karlsson, Erik Holmberg, Dan Lundstedt, Lars Holmberg, Linda Werner, Sasha Koul, Mahnaz Haghanegi, Elisabeth Kjellen, Per Nilsson & Per Malmström, 2020 Jul 15, In: International Journal of Radiation Oncology Biology Physics. 107, 4, p. 701-709 9 p.

    Research output: Contribution to journalArticle

  7. Efficacy and safety of tailored and dose-dense adjuvant chemotherapy and trastuzumab for resected HER2-positive breast cancer: Results from the phase 3 PANTHER trial

    Antroula Papakonstantinou, Alexios Matikas, Nils Olof Bengtsson, Per Malmström, Elham Hedayati, Guenther Steger, Michael Untch, Laila Hübbert, Hemming Johansson, Mats Hellström, Michael Gnant, Sibylle Loibl, Richard Greil, Volker Moebus, Theodoros Foukakis & Jonas Bergh, 2020 Mar 15, In: Cancer. 126, 6, p. 1175-1182 8 p.

    Research output: Contribution to journalArticle

  8. Comprehensive transcriptomic profiling identifies breast cancer patients who may be spared adjuvant systemic therapy

    Martin Sjöström, S. Laura Chang, Nick Fishbane, Elai Davicioni, Linda Hartman, Erik Holmberg, Felix Y. Feng, Corey W. Speers, Lori J. Pierce, Per Malmström, Mårten Fernö & Per Karlsson, 2020 Jan, In: Clinical Cancer Research. 26, 1, p. 171-182 12 p.

    Research output: Contribution to journalArticle

  9. 2019
  10. Clinicogenomic radiotherapy classifier predicting the need for intensified locoregional treatment after breast-conserving surgery for early-stage breast cancer

    Martin Sjöström, S. Laura Chang, Nick Fishbane, Elai Davicioni, Shuang G. Zhao, Linda Hartman, Erik Holmberg, Felix Y. Feng, Corey W. Speers, Lori J. Pierce, Per Malmström, Mårten Fernö & Per Karlsson, 2019 Jan 1, In: Journal of Clinical Oncology. 37, 35, p. 3340-3349 10 p.

    Research output: Contribution to journalArticle

  11. Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities: further results from the prospective PANTHER study with focus on obese patients

    A. Matikas, T. Foukakis, V. Moebus, R. Greil, N. O. Bengtsson, G. G. Steger, M. Untch, H. Johansson, M. Hellström, P. Malmström, M. Gnant, S. Loibl & J. Bergh, 2019, In: Annals of oncology : official journal of the European Society for Medical Oncology. 30, 1, p. 109-114 6 p.

    Research output: Contribution to journalArticle

  12. Effect of Radiotherapy After Breast-Conserving Surgery Depending on the Presence of Tumor-Infiltrating Lymphocytes: A Long-Term Follow-Up of the SweBCG91RT Randomized Trial

    Anikó Kovács, Axel Stenmark Tullberg, Elisabeth Werner Rönnerman, Erik Holmberg, Linda Hartman, Martin Sjöström, Dan Lundstedt, Per Malmström, Mårten Fernö & Per Karlsson, 2019, In: Journal of Clinical Oncology. 37, 14, p. 1179-1187 9 p.

    Research output: Contribution to journalArticle

  13. 2018
  14. Non-linear transformations of age at diagnosis, tumor size, and number of positive lymph nodes in prediction of clinical outcome in breast cancer

    Carina Forsare, Martin Bak, Anna Karin Falck, Dorthe Grabau, Fredrika Killander, Per Malmström, Lisa Rydén, Olle Stål, Marie Sundqvist, Pär Ola Bendahl & Mårten Fernö, 2018 Dec 7, In: BMC Cancer. 18, 1, 1226.

    Research output: Contribution to journalArticle

  15. Identification and validation of single-sample breast cancer radiosensitivity gene expression predictors

    Martin Sjöström, Johan Staaf, Patrik Edén, Fredrik Wärnberg, Jonas Bergh, Per Malmström, Mårten Fernö, Emma Niméus & Irma Fredriksson, 2018 Jul 4, In: Breast Cancer Research. 20, 1, 64.

    Research output: Contribution to journalArticle

  16. Macrophage-derived lipocalin-2 transports iron in the tumor microenvironment

    Christina Mertens, Javier Mora, Bilge Ören, Stephan Grein, Sofia Winslow, Klaus Scholich, Andreas Weigert, Per Malmström, Carina Forsare, Mårten Fernö, Tobias Schmid, Bernhard Brüne & Michaela Jung, 2018, In: OncoImmunology. 7, 3, e1408751.

    Research output: Contribution to journalArticle

  17. 2017
  18. Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancer

    Alexios Matikas, Sara Margolin, Mats Hellström, Hemming Johansson, Nils Olof Bengtsson, Lena Karlsson, Per Edlund, Per Karlsson, Elisabet Lidbrink, Barbro Linderholm, Henrik Lindman, Per Malmstrom, Kenneth Villman, Theodoros Foukakis & Jonas Bergh, 2017 Nov 30, In: Breast Cancer Research and Treatment. 7 p.

    Research output: Contribution to journalArticle

  19. Response to radiotherapy after breast-conserving surgery in different breast cancer subtypes in the Swedish Breast Cancer Group 91 radiotherapy randomized clinical trial

    Martin Sjöström, Dan Lundstedt, Linda Hartman, Erik Holmberg, Fredrika Killander, Anikó Kovács, Per Malmström, Emma Niméus, Elisabeth Werner Rönnerman, Mårten Fernö & Per Karlsson, 2017 Oct 1, In: Journal of Clinical Oncology. 35, 28, p. 3222-3229 8 p.

    Research output: Contribution to journalArticle

  20. Second-look resection for primary stage T1 bladder cancer: a population-based study

    Oliver Patschan, Sten Holmäng, Abolfazl Hosseini, Georg Jancke, Fredrik Liedberg, Börje Ljungberg, Per Uno Malmström, Johan Rosell & Staffan Jahnson, 2017 Mar 28, In: Scandinavian Journal of Urology. 51, 4, p. 301-307 7 p.

    Research output: Contribution to journalArticle

  21. Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013

    Anna Ehinger, Per Malmström, Pär Ola Bendahl, Christopher W. Elston, Anna Karin Falck, Carina Forsare, Dorthe Grabau, Lisa Rydén, Olle Stål & Mårten Fernö, 2017 Jan 2, In: Acta Oncologica. 56, 1, p. 68-74

    Research output: Contribution to journalArticle

  22. Long-term effects on the incidence of second primary cancers in a randomized trial of two and five years of adjuvant tamoxifen

    Johan Rosell, Bo Nordenskjöld, Nils-Olof Bengtsson, Tommy Fornander, Thomas Hatschek, Henrik Lindman, Per Olof Malmström, Arne Wallgren, Olle Stål & John Carstensen, 2017, In: Acta Oncologica. 56, 4, p. 614-617 4 p.

    Research output: Contribution to journalArticle

  23. 2016
  24. Effect of tailored dose-dense chemotherapy vs standard 3-weekly adjuvant chemotherapy on recurrence-free survival among women with high-risk early breast cancer: A randomized clinical trial

    Theodoros Foukakis, Gunter Von Minckwitz, Nils Olof Bengtsson, Yvonne Brandberg, Birgitta Wallberg, Tommy Fornander, Brigitte Mlineritsch, Sabine Schmatloch, Christian F. Singer, Günther Steger, Daniel Egle, Eva Karlsson, Lena Carlsson, Sibylle Loibl, Michael Untch, Mats Hellström, Hemming Johansson, Harald Anderson, Per Malmström, Michael Gnant & 3 others, Richard Greil, Volker Möbus & Jonas Bergh, 2016 Nov 8, In: JAMA: The Journal of the American Medical Association. 316, 18, p. 1888-1896

    Research output: Contribution to journalArticle

  25. No breast cancer subgroup can be spared postoperative radiotherapy after breast-conserving surgery. Fifteen-year results from the Swedish Breast Cancer Group randomised trial, SweBCG 91 RT

    F. Killander, P. Karlsson, H. Anderson, J. Mattsson, E. Holmberg, D. Lundstedt, L. Holmberg & P. Malmström, 2016 Nov 1, In: European Journal of Cancer. 67, p. 57-65 9 p.

    Research output: Contribution to journalArticle

  26. Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma

    Jakob Hedegaard, Philippe Lamy, Iver Nordentoft, Ferran Algaba, Søren Høyer, Benedicte Parm Ulhøi, Søren Vang, Thomas Reinert, Gregers G. Hermann, Karin Mogensen, Mathilde Borg Houlberg Thomsen, Morten Muhlig Nielsen, Mirari Marquez, Ulrika Segersten, Mattias Aine, Mattias Höglund, Karin Birkenkamp-Demtröder, Niels Fristrup, Michael Borre, Arndt Hartmann & 24 others, Robert Stöhr, Sven Wach, Bastian Keck, Anna Katharina Seitz, Roman Nawroth, Tobias Maurer, Cane Tulic, Tatjana Simic, Kerstin Junker, Marcus Horstmann, Niels Harving, Astrid Christine Petersen, M. Luz Calle, Ewout W. Steyerberg, Willemien Beukers, Kim E M van Kessel, Jørgen Bjerggaard Jensen, Jakob Skou Pedersen, Per Uno Malmström, Núria Malats, Francisco X. Real, Ellen C. Zwarthoff, Torben Falck Ørntoft & Lars Dyrskjøt, 2016 Jul 11, In: Cancer Cell. 30, 1, p. 27-42 16 p.

    Research output: Contribution to journalArticle

  27. Gender-related differences in urothelial carcinoma of the bladder: a population-based study from the Swedish National Registry of Urinary Bladder Cancer

    Andreas Thorstenson, Oskar Hagberg, Börje Ljungberg, Fredrik Liedberg, Georg Jancke, Sten Holmäng, Per-Uno Malmström, Abolfazl Hosseini & Staffan Jahnson, 2016, In: Scandinavian Journal of Urology. 50, 4, p. 292-297 6 p.

    Research output: Contribution to journalArticle

  28. Transcriptional profiling of breast cancer metastases identifies liver metastasis-selective genes associated with adverse outcome in luminal A primary breast cancer.

    Siker Kimbung, Ida Johansson, Anna Danielsson, Srinivas Veerla, Suzanne Egyhazi Brage, Marianne Frostvik Stolt, Lambert Skoog, Lena Carlsson, Zakaria Einbeigi, Elisabet Lidbrink, Barbro Kristina Linderholm, Niklas Loman, Per Malmström, Martin Söderberg, Thomas M Walz, Mårten Fernö, Thomas Hatschek & Ingrid Hedenfalk, 2016, In: Clinical Cancer Research. 22, 1, p. 146-157

    Research output: Contribution to journalArticle

  29. 2015
  30. Histological grade provides significant prognostic information in the discrimination between luminal A-like and luminal B-like HER-2 normal subtypes of breast cancer according to St Gallen 2013

    Anna Ehinger, Per Malmström, Pär-Ola Bendahl, Christopher W. Elston, Anna-Karin Falck, Carina Forsare, Dorthe Grabau, Lisa Rydén, Olle Stål & Mårten Fernö, 2015 May 1, In: Cancer Research. 75, 9 Supplement, P6-08-43.

    Research output: Contribution to journalPublished meeting abstract

  31. Use of bacillus Calmette-Guérin in stage T1 bladder cancer: Long-term observation of a population-based cohort.

    Oliver Hultman Patschan, Sten Holmäng, Abolfazl Hosseini, Fredrik Liedberg, Börje Ljungberg, Per Malmström, Johan Rosell & Staffan Jahnson, 2015, In: Scandinavian Journal of Urology. 49, 2, p. 127-132

    Research output: Contribution to journalArticle

  32. 2014
  33. Immunohistochemical assessment of Ki67 with antibodies SP6 and MIB1 in primary breast cancer: a comparison of prognostic value and reproducibility.

    Maria Ekholm, Sanda Beglerbegovic, Dorthe Grabau, Kristina Lövgren, Per Malmström, Linda Werner Hartman & Mårten Fernö, 2014, In: Histopathology. 65, 2, p. 252-260

    Research output: Contribution to journalArticle

  34. Lack of G protein-coupled estrogen receptor (GPER) in the plasma membrane is associated with excellent long-term prognosis in breast cancer.

    Martin Sjöström, Linda Werner Hartman, Dorthe Grabau, Tommy Fornander, Per Malmström, Bo Nordenskjöld, Dennis C Sgroi, Lambert Skoog, Olle Stål, Fredrik Leeb-Lundberg & Mårten Fernö, 2014, In: Breast Cancer Research and Treatment. 145, 1, p. 61-71

    Research output: Contribution to journalArticle

  35. Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial

    H. Bonnefoi, S. Litiere, M. Piccart, G. MacGrogan, P. Fumoleau, E. Brain, T. Petit, P. Rouanet, J. Jassem, C. Moldovan, A. Bodmer, K. Zaman, T. Cufer, M. Campone, E. Luporsi, Per Malmström, G. Werutsky, J. Bogaerts, J. Bergh & D. A. Cameron, 2014, In: Annals of Oncology. 25, 6, p. 1128-1136

    Research output: Contribution to journalArticle

  36. 2013
  37. Breast cancer survival in the US and Europe: a CONCORD high-resolution study

    Claudia Allemani, Milena Sant, Hannah K. Weir, Lisa C. Richardson, Paolo Baili, Hans Storm, Sabine Siesling, Ana Torrella-Ramos, Adri C. Voogd, Tiiu Aareleid, Eva Ardanaz, Franco Berrino, Magdalena Bielska-Lasota, Susan Bolick, Claudia Cirilli, Marc Colonna, Paolo Contiero, Rosemary Cress, Emanuele Crocetti, John P. Fulton & 20 others, Pascale Grosclaude, Timo Hakulinen, M. Isabel Izarzugaza, Per Malmström, Karin Peignaux, Maja Primic-Zakelj, Jadwiga Rachtan, Chakameh Safaei Diba, Maria-Jose Sanchez, Maria J. Schymura, Tiefu Shen, Adele Traina, Laufey Tryggvadottir, Rosario Tumino, Michel Velten, Marina Vercelli, Holly J. Wolf, Anne-Sophie Woronoff, Xiaocheng Wu & Michel P. Coleman, 2013, In: International Journal of Cancer. 132, 5, p. 1170-1181

    Research output: Contribution to journalArticle

  38. Effects of adjuvant tamoxifen therapy on cardiac disease: results from a randomized trial with long-term follow-up

    Johan Rosell, Bo Nordenskjold, Nils-Olof Bengtsson, Tommy Fornander, Thomas Hatschek, Henrik Lindman, Per Malmström, Arne Wallgren, Olle Stal & John Carstensen, 2013, In: Breast Cancer Research and Treatment. 138, 2, p. 467-473

    Research output: Contribution to journalArticle

  39. Grading breast cancer tissues using molecular portraits.

    Niclas Olsson, Petter Skoog, Peter James, Karin M Hansson, Sofia Waldemarson, Per Malmström, Mårten Fernö, Lisa Rydén, Christer Wingren & Carl Borrebaeck, 2013, In: Molecular & Cellular Proteomics. 12, 12, p. 3612-3623

    Research output: Contribution to journalArticle

  40. The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naïve women with N0/N1 primary breast cancer.

    Carina Forsare, Martin Bak, Signe Borgquist, Gunilla Chebil, Anna-Karin Falck, Marie-Louise Fjällskog, Dorthe Grabau, Ingrid Hedenfalk, Karin Jirström, Marie Klintman, Per Malmström, Hans Olsson, Lisa Rydén, Olle Stål, Pär-Ola Bendahl & Mårten Fernö, 2013, In: SpringerPlus. 2, 1, 111.

    Research output: Contribution to journalArticle

  41. The Prognostic Value of Mitotic Activity Index (MAI), Phosphohistone H3 (PPH3), Cyclin B1, Cyclin A, and Ki67, Alone and in Combinations, in Node-Negative Premenopausal Breast Cancer.

    Marie Klintman, Carina Forsare, Cecilia Ahlin, Sanda Beglerbegovic, Marie-Louise Fjällskog, Dorthe Grabau, Einar Gudlaugsson, Emiel A M Janssen, Kristina Lövgren, Ivar Skaland, Pär-Ola Bendahl, Per Malmström, Jan P A Baak & Mårten Fernö, 2013, In: PLoS ONE. 8, 12, e81902.

    Research output: Contribution to journalArticle

  42. The role of AIB1 and PAX2 in primary breast cancer: validation of AIB1 as a negative prognostic factor.

    Sara Alkner, Po Bendahl, Dorthe Grabau, Per Malmström, Mårten Fernö & Lisa Rydén, 2013, In: Annals of Oncology. 24, 5, p. 1244-1252

    Research output: Contribution to journalArticle

  43. 2012
  44. Risk Factors of Developing Long-Lasting Breast Pain After Breast Cancer Radiotherapy

    Dan Lundstedt, Magnus Gustafsson, Gunnar Steineck, Per Malmström, David Alsadius, Agnetha Sundberg, Ulrica Wilderang, Erik Holmberg, Karl-Axel Johansson & Per Karlsson, 2012, In: International Journal of Radiation Oncology, Biology, Physics. 83, 1, p. 71-78

    Research output: Contribution to journalArticle

  45. Snabba åtgärder vid makrohematuri både angelägna och möjliga.

    Fredrik Liedberg, Sten Holmäng, Abolfazl Hosseini, Börje Ljungberg, Per Malmström & Staffan Jahnson, 2012, In: Läkartidningen. 109, 20-21, p. 1034-1035

    Research output: Contribution to journalArticle

Previous 1 2 Next